ea0034p117 | Clinical practice/governance and case reports | SFEBES2014
Bhatti Rahila
, Grimmett Belinda
, McCarthy Maeve
, Agusttson Tomas
, McGowan Barbara
, Powrie Jake
, Carroll Paul
Background: Testosterone replacement is the mainstay of treatment for male hypogonadism. The most commonly reported adverse event in testosterone trials is polycythaemia. This study assessed the prevalence of polycythaemia in males receiving testosterone replacement and compared prevalence rates between different treatment preparations.Methods: 216 men were included in this retrospective observational study conducted from January 2009 to December 2012. 1...